Promising clinical outcomes of sequential and “Sandwich” chemotherapy and extended involved‐field intensity‐modulated radiotherapy in patients with stage <scp>I<sub>E</sub></scp>/<scp>II<sub>E</sub></scp> extranodal natural killer/T‐cell lymphoma
Cancer medicine